The biotech market grew by 12.5% in 2007, to $75 billion, according to IMS Health data. Amgen was the leader of the category, with sales of $15,964 billion.

The market for obesity treatments will grow five-fold by 2016, according to research firm Decision Resources.

Form true partnerships with your clients, keep them happy and make your recommendations short and sweet — that's the message from pharmaceutical companies to their marketing research suppliers and consultants, according to a new study by marketRx, a Cognizant Company.

Last year, the US pharmaceuticals market grew at its slowest rate since 1961, research firm IMS Health said today.

A recent survey of oncologists indicates market share for Genentech's Avastin could more than double as a first-line and second-line breast cancer therapy following last month's approval to treat the disease.

Once a product has been positioned and its brand story told, it's time to develop a creative concept. Cathy Su and Noah Pines look at marketing research techniques that help evolve visual executions, resulting in truly effective ads

Questions over the efficacy of Vytorin and Zetia could prompt a sharp pullback on first- and second-line use of the drug, according to a survey of physicians by GfK Market Measures, but docs are taking a wait-and-see approach with the drugs and remain open to new data.

Three out of five pharmaceutical market research studies—60 % of those fielded in the US and abroad—were conducted online last year, a new study shows.

While data mining laws are mired in the courts, a number of alternatives are proliferating to help states manage costs and help physicians control encounters with sales reps.

Vermont amended its data mining law to avoid constitutional issues that, so far, have undermined similar statutes in other states.